Home > Qtrly Results > MANKIND PHARMA

MANKIND PHARMA
Quarterly Results Analysis [Jun2025]

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Quarterly Results

Consolidated Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Revenues ₹3,570 Cr ₹3,079 Cr ₹3,230 Cr ₹3,077 Cr ₹2,868 Cr ₹2,422 Cr ₹2,607 Cr ₹2,708 Cr
Expenses ₹2,724 Cr ₹2,396 Cr ₹2,400 Cr ₹2,226 Cr ₹2,196 Cr ₹1,836 Cr ₹2,000 Cr ₹2,025 Cr
Operating Income ₹847 Cr ₹683 Cr ₹830 Cr ₹850 Cr ₹672 Cr ₹586 Cr ₹607 Cr ₹683 Cr
Other Income ₹80 Cr ₹251 Cr ₹77 Cr ₹109 Cr ₹99 Cr ₹92 Cr ₹70 Cr ₹60 Cr
Interest ₹171 Cr ₹191 Cr ₹221 Cr ₹7 Cr ₹11 Cr ₹9 Cr ₹9 Cr ₹9 Cr
Depreciation ₹219 Cr ₹231 Cr ₹192 Cr ₹106 Cr ₹103 Cr ₹100 Cr ₹110 Cr ₹96 Cr
Profit Before Tax ₹537 Cr ₹513 Cr ₹494 Cr ₹847 Cr ₹657 Cr ₹570 Cr ₹558 Cr ₹638 Cr
Profit After Tax ₹441 Cr ₹427 Cr ₹381 Cr ₹656 Cr ₹535 Cr ₹475 Cr ₹455 Cr ₹508 Cr
EPS ₹10.62 ₹10.20 ₹9.22 ₹16.31 ₹13.39 ₹11.76 ₹11.33 ₹12.51
Industry Peers & Returns1W1M1Y
MANKIND PHARMA -1.1% 4% 2.8%
SUN PHARMACEUTICAL INDUSTRIES 0.7% -0.7% -13.1%
DIVIS LABORATORIES 0.6% -1.9% 10.9%
CIPLA -0.1% -0.3% -6.1%
TORRENT PHARMACEUTICALS -1% -3% 2.3%
DR REDDYS LABORATORIES 0.6% 3.7% -1.6%
ZYDUS LIFESCIENCES -0.8% 4.9% -7.5%
LUPIN 2.1% 3.1% -9%
AUROBINDO PHARMA -1.2% 0.6% -30.3%

MANKIND PHARMA Quarterly Revenues

Revenues
Q-o-Q

15.94 %

Y-o-Y

24.50 %

Quarters Revenues % Change
Jun2025 ₹3,570 Cr
15.94
Mar2025 ₹3,079 Cr
-4.66
Dec2024 ₹3,230 Cr
4.99
Sep2024 ₹3,077 Cr
7.28
Jun2024 ₹2,868 Cr
18.40
Mar2024 ₹2,422 Cr
-7.09
Dec2023 ₹2,607 Cr
-3.74
Sep2023 ₹2,708 Cr -

MANKIND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

23.94 %

Y-o-Y

26.09 %

Quarters Operating Profit % Change
Jun2025 ₹847 Cr
23.94
Mar2025 ₹683 Cr
-17.67
Dec2024 ₹830 Cr
-2.38
Sep2024 ₹850 Cr
26.58
Jun2024 ₹672 Cr
14.54
Mar2024 ₹586 Cr
-3.33
Dec2023 ₹607 Cr
-11.16
Sep2023 ₹683 Cr -
Operating Margins
Q-o-Q

6.89 %

Y-o-Y

1.28 %

Quarters Operating Margin% % Change
Jun2025 23.72%
6.89
Mar2025 22.19%
-13.62
Dec2024 25.69%
-7.02
Sep2024 27.63%
17.98
Jun2024 23.42%
-3.22
Mar2024 24.2%
4.04
Dec2023 23.26%
-7.74
Sep2023 25.21% -

MANKIND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

3.46 %

Y-o-Y

-17.42 %

Quarters Profit After Tax % Change
Jun2025 ₹441 Cr
3.46
Mar2025 ₹427 Cr
11.96
Dec2024 ₹381 Cr
-41.94
Sep2024 ₹656 Cr
22.77
Jun2024 ₹535 Cr
12.66
Mar2024 ₹475 Cr
4.24
Dec2023 ₹455 Cr
-10.34
Sep2023 ₹508 Cr -
PAT Margins
Q-o-Q

-10.82 %

Y-o-Y

-33.69 %

Quarters PAT Margin(%) % Change
Jun2025 12.36 %
-10.82
Mar2025 13.86 %
17.46
Dec2024 11.8 %
-44.68
Sep2024 21.33 %
14.43
Jun2024 18.64 %
-4.85
Mar2024 19.59 %
12.20
Dec2023 17.46 %
-6.88
Sep2023 18.75 % -

MANKIND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

4.12 %

Y-o-Y

-20.69 %

Quarters EPS % Change
Jun2025 ₹10.62
4.12
Mar2025 ₹10.2
10.63
Dec2024 ₹9.22
-43.47
Sep2024 ₹16.31
21.81
Jun2024 ₹13.39
13.86
Mar2024 ₹11.76
3.80
Dec2023 ₹11.33
-9.43
Sep2023 ₹12.51 -

You may also like the below Video Courses